scholarly article | Q13442814 |
P50 | author | Guey-Jen Lee-Chen | Q88031050 |
P2093 | author name string | Ming-Tsan Su | |
Shu-Ling Chen | |||
Ying-Chieh Sun | |||
Hsin-Yu Huang | |||
Guan-Chiun Lee | |||
Hsiu Mei Hsieh-Li | |||
Hei-Jen Huang | |||
P2860 | cites work | WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids. | Q51972188 |
Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. | Q52142981 | ||
Deciphering the role of ferulic acid against streptozotocin-induced cellular stress in the cardiac tissue of diabetic rats. | Q52840409 | ||
[Alzheimer's disease and diabetes - the common pathogenesis]. | Q53132187 | ||
[Oxidative stress promotes hepatocyte apoptosis mediated by glycogen synthase kinase 3β]. | Q53648546 | ||
Hyperglycemia Enhances the Production of Amyloid β1-42 in the Lenses of Otsuka Long-Evans Tokushima Fatty Rats, a Model of Human Type 2 Diabetes | Q38782401 | ||
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling | Q38823998 | ||
17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner. | Q40021016 | ||
Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice | Q40527526 | ||
Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction | Q40568267 | ||
Neurobiology of Alzheimer's disease | Q41864156 | ||
Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors | Q42178082 | ||
Intracellular accumulation of amyloid-β (Aβ) protein plays a major role in Aβ-induced alterations of glutamatergic synaptic transmission and plasticity. | Q42465835 | ||
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease | Q42474769 | ||
Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease | Q44132132 | ||
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. | Q44719973 | ||
Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway | Q44969807 | ||
Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis | Q45032434 | ||
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. | Q46163967 | ||
AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity | Q46241956 | ||
Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats | Q46426993 | ||
Activation of endocannabinoid transmission induces antidepressant-like effects in rats. | Q46487164 | ||
Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats | Q46660450 | ||
Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD. | Q47313449 | ||
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link | Q47381948 | ||
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties | Q48324018 | ||
Cannabinoids modulate hippocampal memory and plasticity | Q48433767 | ||
Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections | Q48764154 | ||
Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice | Q48846848 | ||
Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice | Q48901829 | ||
Hyperglycemia Increases the Production of Amyloid Beta-Peptide Leading to Decreased Endothelial Tight Junction | Q48930602 | ||
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling | Q50113929 | ||
Alzheimer's Disease | Q22248111 | ||
Global prevalence of dementia: a Delphi consensus study | Q24603249 | ||
Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents | Q24613945 | ||
Endogenous cannabinoid signaling is essential for stress adaptation | Q24631883 | ||
Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system | Q28182188 | ||
New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry | Q28290064 | ||
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 | ||
Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation | Q33556064 | ||
A phase II trial of tideglusib in Alzheimer's disease | Q34042842 | ||
Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis | Q34078130 | ||
The role of tau kinases in Alzheimer's disease | Q34138413 | ||
Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice | Q34479091 | ||
Endothelial nitric oxide modulates expression and processing of amyloid precursor protein | Q34720034 | ||
The GSK3 signaling pathway is activated by cocaine and is critical for cocaine conditioned reward in mice | Q35088414 | ||
The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease | Q35944243 | ||
Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection. | Q36109697 | ||
Administration of NaHS Attenuates Footshock-Induced Pathologies and Emotional and Cognitive Dysfunction in Triple Transgenic Alzheimer's Mice | Q36316228 | ||
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling | Q36378223 | ||
Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment | Q36423441 | ||
Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model | Q37089126 | ||
Impaired glycemia increases disease progression in mild cognitive impairment | Q37489320 | ||
Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays | Q38776993 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | hyperglycemia | Q271993 |
cognitive dysfunction | Q57859955 | ||
P304 | page(s) | 763-773 | |
P577 | publication date | 2018-11-13 | |
P1433 | published in | Psychopharmacology | Q1422802 |
P1476 | title | Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice | |
P478 | volume | 236 |
Q92535276 | Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity | cites work | P2860 |
Search more.